EDN1 and diabetic cardiomyopathy: Diabetic cardiomyopathy is associated with changes in the expression and bioavailability of vasoactive factors released from the endothelium of coronary microvasculature, including upregulation of endothelin-1 (ET-1) and downregulation of nitric oxide (NO) [29].